Getting a fine needle biopsy from an ocular melanoma can reveal information about one's prognosis - whether a person has a low risk or a higher risk of getting spread of the cancer (metastasis) in the future. Regardless of how this result is used, biopsy results provide more information to patients about the nature of their cancer. Performing this "prognostic biopsy" is the standard of care at the majority of centers where ocular melanoma is treated. However, there are some centers that do not perform tumor biopsy for prognosis - why?
Each major eye tumor center with over 10-15 years of biopsy experience has published their results - it is overwhelming clear that biopsy does NOT increase the risk of metastasis in ocular melanoma patients. Listen to hear my thoughts on why although the data is clear, some individuals prefer not to change their practice patterns.
Welcome to Finding Your Way with Ocular Melanoma, a guide to understanding everything there is to know about your experience with this rare cancer. Learn through the lens of my knowledge and clinical experience as a physician expert and passionate patient advocate. The more you know about ocular melanoma, the better you will do, and the better you will live. Let's go!
The content shared on the Finding Your Way with Ocular Melanoma podcast is for informational and educational purposes only and does not constitute medical advice. The information provided must not be used as a substitute for professional medical advice, diagnosis, or treatment. As a listener, you are responsible for your own health-related decisions and must consider consulting with a healthcare professional for personalized medical advice.
Tara McCannel MD PhD is a an ocular oncologist, vitreoretinal surgeon and co-founder of Seyhart Wellness. She is also the host of the Mind Body MD podcast where she shares her passion for holistic health and wellness.
